作者
Benjamin L. Wright,J. Pablo Abonia,Edsel M. Abud,Seema S. Aceves,Steven J. Ackerman,Melinda Braskett,Joy W. Chang,Mirna Chehade,Gregory Constantine,Carla M. Davis,Evan S. Dellon,Alfred D. Doyle,Raquel Durban,David A. Hill,Elizabeth T. Jensen,Anupama Kewalramani,Paneez Khoury,Amy D. Klion,Leah C. Kottyan,Fei Li Kuang,Emily C. McGowan,Melanie A. Ruffner,Lisa A. Spencer,Jonathan M. Spergel,Amiko M. Uchida,Joshua B. Wechsler,Robert D. Pesek
摘要
The Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and The International Gastrointestinal Eosinophil Researchers (TIGERS) organized a day-long symposium at the 2024 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured new discoveries in basic and translational research and debates on the mechanisms and management of eosinophilic gastrointestinal diseases (EGIDs). Updates on recent clinical trials and consensus guidelines were also presented. Herein, we summarize the updates on EGIDs presented at the symposium.